Cargando…
CRBN is downregulated in lung cancer and negatively regulates TLR2, 4 and 7 stimulation in lung cancer cells
Autores principales: | Kim, Mi‐Jeong, Lee, Ji Su, Kim, Ji Young, Choi, Bongkum, Son, Juhee, Min, Yoon, Jeong, Soo‐Kyung, Kim, Duk‐Hwan, Lee, Joo Sang, Chun, Eunyoung, Lee, Ki‐Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513676/ https://www.ncbi.nlm.nih.gov/pubmed/36164994 http://dx.doi.org/10.1002/ctm2.1050 |
Ejemplares similares
-
β‐arrestin 2 negatively regulates lung cancer progression by inhibiting the TRAF6 signaling axis for NF-κB activation and autophagy induced by TLR3 and TLR4
por: Kim, Ji Young, et al.
Publicado: (2023) -
FFAR2 antagonizes TLR2- and TLR3-induced lung cancer progression via the inhibition of AMPK-TAK1 signaling axis for the activation of NF-κB
por: Kim, Mi-Jeong, et al.
Publicado: (2023) -
USP8 regulates liver cancer progression via the inhibition of TRAF6-mediated signal for NF-κB activation and autophagy induction by TLR4
por: Kim, Mi-Jeong, et al.
Publicado: (2021) -
AMPKα1 Regulates Lung and Breast Cancer Progression by Regulating TLR4-Mediated TRAF6-BECN1 Signaling Axis
por: Kim, Mi-Jeong, et al.
Publicado: (2020) -
USP15 negatively regulates lung cancer progression through the TRAF6-BECN1 signaling axis for autophagy induction
por: Kim, Mi-Jeong, et al.
Publicado: (2022)